Literature DB >> 17364504

Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-alpha-induced cytotoxicity.

Stephen D Hsu1, Douglas P Dickinson, Haiyan Qin, James Borke, Kalu U E Ogbureke, Julia N Winger, Amy M Camba, Wendy B Bollag, Hubert J Stöppler, Mohamed M Sharawy, George S Schuster.   

Abstract

Sjogren's syndrome (SS) is a relatively common autoimmune disorder. A key feature of SS is lymphocytic infiltration of the salivary and lacrimal glands, associated with the destruction of secretory functions of these glands. Current treatment of SS targets the symptoms but is unable to reduce or prevent the damage to the glands. We reported previously that the major green tea polyphenol (GTP) epigallocatechin-3-gallate (EGCG) inhibits autoantigen expression in normal human keratinocytes and immortalized normal human salivary acinar cells (Hsu et al. 2005). However, it is not known whether GTPs have this effect in vivo, if they can reduce lymphocytic infiltration, or protect salivary acinar cells from tumor necrosis factor-alpha (TNF-alpha)-induced cytotoxicity. Here, we demonstrate that in the NOD mouse, a model for human SS, oral administration of green tea extract reduced the serum total autoantibody levels and the autoimmune-induced lymphocytic infiltration of the submandibular glands. Further, we show that EGCG protected normal human salivary acinar cells from TNF-alpha-induced cytotoxicity. This protection was associated with specific phosphorylation of p38 MAPK, and inhibitors of the p38 MAPK pathway blocked the protective effect. In conclusion, GTPs may provide a degree of protection against autoimmune-induced tissue damage in SS, mediated in part through activation of MAPK elements.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364504     DOI: 10.1080/08916930601167343

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  17 in total

1.  Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune disease.

Authors:  Kevin Gillespie; Isamu Kodani; Douglas P Dickinson; Kalu U E Ogbureke; Amy M Camba; Mengjie Wu; Stephen Looney; Tin-Chun Chu; Haiyan Qin; Frederick Bisch; Mohamed Sharawy; George S Schuster; Stephen D Hsu
Journal:  Life Sci       Date:  2008-09-06       Impact factor: 5.037

2.  Exogenous expression of caspase-14 induces tumor suppression in human salivary cancer cells by inhibiting tumor vascularization.

Authors:  Mengjie Wu; Isamu Kodani; Douglas Dickinson; Frank Huff; Kalu U E Ogbureke; Haiyan Qin; Senthil Arun; Rachel Dulebohn; Mohamed Al-Shabrawey; Amany Tawfik; Susan Prater; Jill Lewis; John Wataha; Regina Messer; Stephen Hsu
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

3.  Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets.

Authors:  Junpeng Wang; Zhihong Ren; Yanmei Xu; Sheng Xiao; Simin N Meydani; Dayong Wu
Journal:  Am J Pathol       Date:  2011-11-03       Impact factor: 4.307

4.  Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice.

Authors:  Zhuo Fu; Wei Zhen; Julia Yuskavage; Dongmin Liu
Journal:  Br J Nutr       Date:  2010-12-09       Impact factor: 3.718

5.  Ruscogenin Ameliorated Sjögren's Syndrome by Inhibiting NLRP3 Inflammasome Activation.

Authors:  Jing He; Yue Wang; Lei Xu; Changsong Xu; Yamei Zhu; Meimei Xu; Yueyue Chen; Liang Guo; Wei Hu; Dake Xu; Rongyue Jing; Bo Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-28       Impact factor: 2.650

6.  Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway.

Authors:  Douglas Dickinson; Hongfang Yu; Seiji Ohno; Cristina Thomas; Scott Derossi; Yat-Ho Ma; Nicole Yates; Emily Hahn; Frederick Bisch; Tetsuya Yamamoto; Stephen Hsu
Journal:  Inflamm Allergy Drug Targets       Date:  2014-02

Review 7.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

8.  Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.

Authors:  Salahuddin Ahmed; Hubert Marotte; Kevin Kwan; Jeffrey H Ruth; Phillip L Campbell; Bradley J Rabquer; Angela Pakozdi; Alisa E Koch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

Review 9.  Immunomodulatory Effects of Green Tea Polyphenols.

Authors:  Shuzhen Wang; Zhiliang Li; Yuting Ma; Yan Liu; Chi-Chen Lin; Shiming Li; Jianfeng Zhan; Chi-Tang Ho
Journal:  Molecules       Date:  2021-06-20       Impact factor: 4.411

10.  A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease.

Authors:  Fan Yu; Min Zheng; Alice Yang Zhang; Zongchao Han
Journal:  J Control Release       Date:  2019-10-24       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.